PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

nisoldipine

Verify with FDA → · CMS NADAC pricing →

Brand names: Sular

Calcium Channel Blocker Rx

Nisoldipine is a medicine to treat high blood pressure. It belongs to a class of drugs called calcium channel blockers.

Drug Pricing (NADAC)

Generic Price

$3.62/unit

Generic Available

Yes (2 manufacturers)

Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →

What it does

Nisoldipine extended-release tablets are used to treat high blood pressure.

Common side effects

Swelling in your legs or ankles, Headache, Dizziness

Key warnings

If you are allergic to dihydropyridine calcium channel blockers, you should not take this medicine.

How It Works

Nisoldipine blocks calcium from entering certain cells. This helps to relax and widen blood vessels. As a result, blood can flow more easily, which lowers blood pressure.

How to Take It

Take nisoldipine extended-release tablets once a day. Take it on an empty stomach, either 1 hour before or 2 hours after eating. Swallow the tablets whole; do not crush, chew, or break them. Your doctor may start you on a low dose and increase it slowly.

Pregnancy & Breastfeeding

Tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. It is not known if nisoldipine will harm your unborn baby or pass into breast milk.

Missed Dose

If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule.

Storage

Store nisoldipine at room temperature (68° to 77°F) away from light and moisture.

Side Effects (from patient reports)

Based on 707 FDA adverse event reports.

Feeling sick to your stomach
88
The medicine is not working
79
Feeling lightheaded or unsteady
77
Pain in your head
76
Feeling very tired
74
Kidneys stop working
65
Discomfort
64
Difficulty breathing
63
Weakness
62
Loose or watery stools
59

FDA Adverse Event Report Analysis

Detailed analysis of 1,191 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2004–2025.

Total Reports

1,191

Death-Related Reports

123

Hospitalization Reports

394

Top Indication

Hypertension

Gender Distribution

Female 723 (62%)
Male 439 (38%)

Age Distribution

18–44 51
45–64 264
65–74 189
75+ 242

Most Reported Adverse Reactions (FAERS)

# Reaction Reports
1 NAUSEA 88
2 DRUG INEFFECTIVE 79
3 DIZZINESS 77
4 HEADACHE 76
5 FATIGUE 74
6 RENAL FAILURE 65
7 PAIN 64
8 DYSPNOEA 63
9 ASTHENIA 62
10 DIARRHOEA 59
11 ANXIETY 54
12 MYOCARDIAL INFARCTION 54
13 OEDEMA PERIPHERAL 54
14 HYPERTENSION 50
15 PRURITUS 49

Reactions in Death Reports

DEATH 39
RENAL FAILURE 21
MYOCARDIAL INFARCTION 19
COMPLETED SUICIDE 17
INJURY 14
ASTHENIA 13
CARDIAC FAILURE CONGESTIVE 12
PAIN 12
PNEUMONIA 12
ANXIETY 11

Reactions in Hospitalization Reports

DYSPNOEA 43
MYOCARDIAL INFARCTION 39
CARDIAC FAILURE CONGESTIVE 35
RENAL FAILURE 35
ASTHENIA 34
NAUSEA 33
PAIN 33
ANXIETY 31
CEREBROVASCULAR ACCIDENT 31
PNEUMONIA 31

Source: FDA FAERS (Adverse Event Reporting System) FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation

Serious Warnings

If you are allergic to dihydropyridine calcium channel blockers, you should not take this medicine.

Known Drug Interactions

Calcium Channel Blockers Felodipine a Nisoldipine Contraindicated during and 2 weeks after itraconazole treatment.

Mechanism: Itraconazole blocks the enzymes that clear nisoldipine from your body, causing the drug to build up to unsafe levels.

What to do: You should not use these medications at the same time or within two weeks of finishing your itraconazole treatment.

Phenytoin when given with the combination of fosamprenavir and ritonavir may increase the concentration of amprenavir Calcium channel blockers Nifedipine, nimodipine, nisoldipine, verapamil Other Albendazole (decreases active metabolite), chlorpropamide, clozapine, cyclosporine, digoxin, disopyramide, folic acid, methadone, mexiletine, praziquantel, quetiapine a The effect of phenytoin on phenobarbital, valproic acid and sodium valproate serum levels is unpredictable 7.3 Drug/Laboratory Test Interactions Care should be taken when using immunoanalytical methods to measure serum phenytoin con...

Mechanism: Phenytoin makes your body clear nisoldipine out of your system more quickly, which can make this blood pressure medicine less effective.

What to do: Your doctor may need to monitor your blood pressure and adjust your nisoldipine dosage as needed.

Common Questions

Can I cut the pill in half?
No, swallow the tablet whole. Do not bite, divide, or crush it.
What should I avoid while taking this medicine?
Avoid grapefruit products before and after taking nisoldipine.
What is the starting dose?
The usual starting dose is 17 mg once daily.
What is the usual maintenance dose?
The usual maintenance dose is 17 mg to 34 mg once daily.
Can I take this with other blood pressure medicines?
Yes, nisoldipine can be used safely with diuretics, ACE inhibitors, and beta-blocking agents.
What if I am over 65 or have liver problems?
Your doctor may start you on a lower dose (not exceeding 8.5 mg daily) and monitor your blood pressure closely.
What should I do if I experience swelling in my ankles?
Talk to your doctor. Swelling in the legs or ankles is a common side effect, but your doctor can help manage it.
How long will I need to take this medication?
Continue taking nisoldipine as prescribed by your doctor. Do not stop taking it without talking to your doctor first.
What do the tablets look like?
The tablets come in different colors and strengths. The 8.5 mg tablets are beige, the 17 mg tablets are yellow, the 25.5 mg tablets are light orange, and the 34 mg tablets are orange.
What if I think I'm having a serious side effect?
Contact your doctor right away.
What are the common side effects of nisoldipine?
The most commonly reported side effects of nisoldipine include Swelling in your legs or ankles, Headache, Dizziness, Sore throat, Flushing. Based on 707 FDA adverse event reports. Always consult your healthcare provider about potential side effects.
Does nisoldipine interact with other medications?
Yes, nisoldipine has 2 known drug interactions. Notable interactions include itraconazole, phenytoin. Always inform your doctor about all medications you are taking.
What drug class is nisoldipine?
nisoldipine belongs to the Calcium Channel Blocker drug class. It requires a prescription (Rx). Nisoldipine extended-release tablets are used to treat high blood pressure.
Is nisoldipine safe during pregnancy?
Tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. It is not known if nisoldipine will harm your unborn baby or pass into breast milk. Always consult your healthcare provider before using any medication during pregnancy or breastfeeding.

Related Medications in Calcium Channel Blocker

Other drugs grouped near nisoldipine — same-class peers and common alternatives.

Compare nisoldipine vs acebutolol side-by-side →

Medication Guides

Related Health & Safety Data

Save on nisoldipine

Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.

Disclosure: This link may earn us a commission at no extra cost to you. See our terms.

What the FDA Data Shows for nisoldipine

The FDA label for nisoldipine (sold under brand names such as Sular) classifies it as a prescription-only medication in the Calcium Channel Blocker class. Nisoldipine extended-release tablets are used to treat high blood pressure. Official labeling lists 5 commonly reported side effects, including Swelling in your legs or ankles, Headache, Dizziness.

Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 707 voluntary reports. The database also lists 2 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated major severity. NADAC pricing from CMS shows a generic unit cost of $3.62.

Report counts do not establish causation — a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information further shape supply and switching decisions. This page summarizes public FDA data for educational purposes only and is not a substitute for professional medical advice — always consult a licensed healthcare provider before starting, stopping, or changing any medication.

Data Sources

Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).

FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. Always consult a healthcare professional before making medication decisions.

Last updated: September 30, 2022

All federal data sources used on this page